Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Radius Health (developing therapeutics for women's health, osteoporosis, and inflammation) has raised $29mm in the first closing of its Series C financing round (what the company calls its "second institutional financing"). It plans to bring in an additional $28.5mm in a second closing; at that point, Radius will have raised $81.5mm since its 2003 inception. Existing backer MPM Capital and new investor the Wellcome Trust co-led the first tranche, and were joined by HealthCare Ventures and Oxford Bioscience Partners (both existing investors) and additional newcomers BB Biotech and the Scottish Widows Investment Partnership.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?